Contact
Please use this form to send email to PR contact of this press release:
BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany
TO:
Please use this form to send email to PR contact of this press release:
BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany
TO: